Sampson JH - Search Results

1

Immunotherapy for primary brain tumors: no longer a matter of privilege.

Fecci PE, Heimberger AB, Sampson JH. Fecci PE, et al. Among authors: sampson jh. Clin Cancer Res. 2014 Nov 15;20(22):5620-9. doi: 10.1158/1078-0432.CCR-14-0832. Clin Cancer Res. 2014. PMID: 25398845 Free PMC article. Review.

2

Treatment of neoplastic meningitis with intrathecal temozolomide.

Sampson JH, Archer GE, Villavicencio AT, McLendon RE, Friedman AH, Bishop WR, Bigner DD, Friedman HS. Sampson JH, et al. Clin Cancer Res. 1999 May;5(5):1183-8. Clin Cancer Res. 1999. PMID: 10353755

3

Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.

Archer GE, Sampson JH, Lorimer IA, McLendon RE, Kuan CT, Friedman AH, Friedman HS, Pastan IH, Bigner DD. Archer GE, et al. Among authors: sampson jh. Clin Cancer Res. 1999 Sep;5(9):2646-52. Clin Cancer Res. 1999. PMID: 10499644

4

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.

Heimberger AB, Crotty LE, Archer GE, McLendon RE, Friedman A, Dranoff G, Bigner DD, Sampson JH. Heimberger AB, et al. Among authors: sampson jh. J Neuroimmunol. 2000 Feb 1;103(1):16-25. doi: 10.1016/s0165-5728(99)00172-1. J Neuroimmunol. 2000. PMID: 10674985

5

Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.

Heimberger AB, Archer GE, McLendon RE, Hulette C, Friedman AH, Friedman HS, Bigner DD, Sampson JH. Heimberger AB, et al. Among authors: sampson jh. Clin Cancer Res. 2000 Oct;6(10):4148-53. Clin Cancer Res. 2000. PMID: 11051269

6

Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma.

Heimberger AB, Archer GE, Crotty LE, McLendon RE, Friedman AH, Friedman HS, Bigner DD, Sampson JH. Heimberger AB, et al. Among authors: sampson jh. Neurosurgery. 2002 Jan;50(1):158-64; discussion 164-6. doi: 10.1097/00006123-200201000-00024. Neurosurgery. 2002. PMID: 11844246

7

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

Reardon DA, Akabani G, Coleman RE, Friedman AH, Friedman HS, Herndon JE 2nd, Cokgor I, McLendon RE, Pegram CN, Provenzale JM, Quinn JA, Rich JN, Regalado LV, Sampson JH, Shafman TD, Wikstrand CJ, Wong TZ, Zhao XG, Zalutsky MR, Bigner DD. Reardon DA, et al. Among authors: sampson jh. J Clin Oncol. 2002 Mar 1;20(5):1389-97. doi: 10.1200/JCO.2002.20.5.1389. J Clin Oncol. 2002. PMID: 11870184 Clinical Trial.

8

Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).

Heimberger AB, Learn CA, Archer GE, McLendon RE, Chewning TA, Tuck FL, Pracyk JB, Friedman AH, Friedman HS, Bigner DD, Sampson JH. Heimberger AB, et al. Among authors: sampson jh. Clin Cancer Res. 2002 Nov;8(11):3496-502. Clin Cancer Res. 2002. PMID: 12429640

9

Viruses in the treatment of brain tumors.

Fecci PE, Gromeier M, Sampson JH. Fecci PE, et al. Among authors: sampson jh. Neuroimaging Clin N Am. 2002 Nov;12(4):553-70. doi: 10.1016/s1052-5149(02)00028-x. Neuroimaging Clin N Am. 2002. PMID: 12687911 Review.

10

Clinical immunotherapy for brain tumors.

Fecci PE, Sampson JH. Fecci PE, et al. Among authors: sampson jh. Neuroimaging Clin N Am. 2002 Nov;12(4):641-64. doi: 10.1016/s1052-5149(02)00027-8. Neuroimaging Clin N Am. 2002. PMID: 12687917 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters